BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37007164)

  • 1. Case report: The stroma-rich variant of Castleman's disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node.
    Shi X; Liao M; Yin X; Chen Y; Huang C; Yin W; Li J
    Front Oncol; 2023; 13():1008587. PubMed ID: 37007164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stroma-rich variant of hyaline-vascular Castleman's disease: a clinicopathologic and histogenetic study].
    Xiong Y; Zhang Y; Wang Y; Na J; Li T
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):14-8. PubMed ID: 20388393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare stroma-rich variant of hyaline-vascular Castleman's disease associated with calcifying fibrous pseudotumor.
    Ma H; Jiang M; Xiao W
    Int J Clin Exp Pathol; 2015; 8(3):3362-4. PubMed ID: 26045869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiomyoid proliferative lesion: an unusual stroma-rich variant of Castleman's disease of hyaline-vascular type.
    Izumi M; Mochizuki M; Kuroda M; Iwaya K; Mukai K
    Virchows Arch; 2002 Oct; 441(4):400-5. PubMed ID: 12404066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyaline vascular Castleman disease of the kidney: case report and literature review.
    Li Y; Zhao H; Su B; Yang C; Li S; Fu W
    Diagn Pathol; 2019 Aug; 14(1):94. PubMed ID: 31439011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mediastinal angiofolicular lymphoid hyperplasia--Castleman's disease--case report].
    Sousa V; Carvalho L
    Rev Port Pneumol; 2006; 12(3):275-80. PubMed ID: 16967177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic variant of follicular lymphoma reminiscent of hyaline-vascular Castleman disease.
    Koh J; Jeon YK
    J Pathol Transl Med; 2020 May; 54(3):253-257. PubMed ID: 32013324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyneuropathy in Osteosclerotic Myeloma Coexisting With Hyaline Vascular Castleman's Disease.
    Sahota P; Das CP; Prabhakar S; Rajwanshi A; Singh P; Khurana D
    J Clin Neuromuscul Dis; 2005 Sep; 7(1):29-35. PubMed ID: 19078779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells.
    Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D
    Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis.
    Danon AD; Krishnan J; Frizzera G
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):369-82. PubMed ID: 8116226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Follicular variant" of hyaline-vascular type of Castleman's disease: histopathological and immunohistochemical study of 11 cases.
    Kojima M; Shimizu K; Ikota H; Ohno Y; Motoori T; Itoh H; Masawa N; Nakamura S
    J Clin Exp Hematop; 2008 Nov; 48(2):39-45. PubMed ID: 19039195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies.
    Chan AC; Chan KW; Chan JK; Au WY; Ho WK; Ng WM
    Histopathology; 2001 Jun; 38(6):510-8. PubMed ID: 11422494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases.
    Zarate-Osorno A; Medeiros LJ; Danon AD; Neiman RS
    Arch Pathol Lab Med; 1994 Mar; 118(3):270-4. PubMed ID: 8135630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman's disease in a schizophrenic patient.
    Katano H; Kaneko K; Shimizu S; Saito T; Irié T; Mori S
    Pathol Int; 1997 Oct; 47(10):703-6. PubMed ID: 9361105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical case of Castleman's disease.
    Macedo JE; Abreu I; Marques M; Henrique R; Araújo A
    J Thorac Oncol; 2007 Mar; 2(3):259-60. PubMed ID: 17410052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sjögren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia.
    Higashi K; Matsuki Y; Hidaka T; Aida S; Suzuki K; Nakamura H
    Scand J Rheumatol; 1997; 26(6):482-4. PubMed ID: 9433413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castleman's disease: atypical manifestation in an 11-year-old girl.
    Gidvani VK; Tyree MM; Bhowmick SK
    South Med J; 2001 Feb; 94(2):250-3. PubMed ID: 11235046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of interleukin-6 and vascular endothelial growth factor by spindle cell sarcoma complicating Castleman's disease (so-called 'vascular neoplasia').
    Kakiuchi C; Ishida T; Sato H; Katano H; Ishiko T; Mukai H; Kogi M; Kasuga N; Takeuchi K; Yamane K; Fukayama M; Mori S
    J Pathol; 2002 Jun; 197(2):264-71. PubMed ID: 12015752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.